Cyclacel Pharmaceuticals Inc.
13F holders, Q2 2025 (June 30)15holders
2famous investors
$0.33avg. 13F price*
At the end of Q2 2025, 15 institutions reported holding Cyclacel Pharmaceuticals Inc. in their 13F filings. The largest holders were Citadel Advisors ($59K), HRT Financial LP ($22K) and XTX Topco Ltd ($12K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Cyclacel Pharmaceuticals Inc.
- CUSIP
- 23254L884
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 14 | $109K |
| Exits | 0 | $0 |
Ownership 15 holders
| Citadel Advisors | 0.00% | New | 179,555 | $59K |
| HRT Financial LP | 0.00% | New | 69,568 | $22K |
| XTX Topco Ltd | 0.00% | New | 36,858 | $12K |
| Two Sigma Securities, LLC | 0.00% | New | 19,905 | $7K |
| Millennium Management | 0.00% | New | 14,093 | $5K |
| UBS Group AG | 0.00% | New | 5,985 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 5,809 | $2K |
| Financial Gravity Companies, Inc. | 0.00% | — | 13 | $4 |
| Archer Investment Corp | 0.00% | New | 13 | $4 |
| Activest Wealth Management | 0.00% | New | 8 | $3 |
| Morgan Stanley | 0.00% | New | 5 | $2 |
| Osaic Holdings, Inc. | 0.00% | New | 8 | $2 |
| Bank of America Corp. | 0.00% | New | 3 | $1 |
| Wells Fargo & Company | 0.00% | New | 2 | $1 |
| Signaturefd, LLC | 0.00% | New | 1 | $0 |
"% of holder's portfolio" is CYCLACEL PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Cyclacel Pharmaceuticals Inc. the manager owns.